LAB vs TRGP · rev $174.4M vs P/E 32, rev $16.38B
Standard Biotools Inc (LAB) versus Targa Resources Inc (TRGP) — a side-by-side from cached financials, not a winner call.
Standard Biotools Inc (LAB) is a medical devices company listed on NASDAQ.
Targa Resources Inc (TRGP) is a oil & gas midstream company listed on US.
Latest reported LAB revenue for 2024-12-31 was $174.4M. Net income was -$138.9M. Revenue was up 64.0% from 2023-12-31 to 2024-12-31. LAB currently screens at market cap $317.1M.
Latest reported TRGP revenue for 2024-12-31 was $16.38B. Net income was $1.55B. Revenue was up 2.0% from 2023-12-31 to 2024-12-31. TRGP currently screens at market cap $37.64B and trailing P/E 32.0.
LAB currently screens at market cap $317.1M. TRGP currently screens at market cap $37.64B and trailing P/E 32.0.
Not investment advice. Open the LAB and TRGP stock pages for the full models.
Not investment advice.